Related Experiment Video

Updated: Aug 7, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Induction of apoptosis in CTLL-2 cells by protocatechualdehyde

Y Wang1, T Hasuma, Y Yano

  • 1Department of Biochemistry, Osaka City University Medical School, Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.

Anticancer Research
|June 9, 2001
PubMed

Insights

Protocatechualdehyde (PA) inhibits cytotoxic T cell proliferation by inducing apoptosis. This compound suppresses key proteins involved in cell survival, offering potential as a novel therapeutic agent.

Area of Science:

  • Molecular Biology
  • Immunology
  • Pharmacology

Background:

  • Cytotoxic T cells (CTLL-2) play a crucial role in immune responses.
  • Interleukin-2 (IL-2) is vital for T cell proliferation and survival.
  • Understanding the molecular basis of T cell proliferation inhibition is key for therapeutic development.

Purpose of the Study:

  • To investigate the molecular mechanisms behind protocatechualdehyde's (PA) antiproliferative effects on IL-2-stimulated cytotoxic T cells (CTLL-2).
  • To determine if PA induces apoptosis and identify the specific signaling pathways involved.

Main Methods:

  • Cell viability assays were performed on CTLL-2 cells treated with varying concentrations of PA.
  • Apoptosis was assessed using DNA fragmentation assays.
  • Protein phosphorylation patterns (tyrosine and serine/threonine) were analyzed.
  • Expression levels of bcl-2 and bax proteins, as well as caspase-3 activity, were measured.

Main Results:

  • Protocatechualdehyde (PA) significantly inhibited CTLL-2 cell viability starting at 0.12 mM.
  • PA induced apoptosis, evidenced by DNA fragmentation (DNA ladder) at 0.12 mM and more intensely at 0.3 mM.
  • PA suppressed IL-2-dependent tyrosine phosphorylation of 91, 80, and 55 KDa proteins but did not affect serine/threonine phosphorylation.
  • PA reduced bcl-2 protein and mRNA levels while increasing caspase-3 activity; bax protein levels remained unchanged.

Conclusions:

  • Protocatechualdehyde (PA) effectively inhibits cytotoxic T cell proliferation and induces apoptosis through specific molecular pathways.
  • PA's mechanism involves suppressing tyrosine phosphorylation and downregulating bcl-2, leading to caspase-3 activation.
  • PA demonstrates potential as a potent antiproliferative agent and a promising candidate for novel therapeutic strategies.

More Related Videos

An In Vitro Approach to Photodynamic Therapy04:53

An In Vitro Approach to Photodynamic Therapy

Published on: August 17, 2018

Experimental Analysis of Apoptotic Thymocyte Engulfment by Macrophages06:47

Experimental Analysis of Apoptotic Thymocyte Engulfment by Macrophages

Published on: May 24, 2019

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...